American Journal Of Cardiovascular Drugs

Journal Title：American Journal Of Cardiovascular Drugs

Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.

Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.

The American Journal of Cardiovascular Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

《美国心血管药物杂志》在心脏病学学科内推广合理治疗，涵盖了心血管疾病治疗的所有方面，尤其是在治疗新药和成熟药物中的地位。

通过一系列评论和原创临床研究文章，该杂志解决了与治疗这些疾病相关的主要问题，包括主要类别药物的药理学、功效和副作用；有关新开发药物和药物类别的信息；对心血管疾病病因学的最新研究的治疗意义；以及具体临床情况的实际管理。

《美国心血管药物杂志》提供了一系列额外的增强功能，旨在提高期刊内容的知名度、读者群和教育价值。每篇文章都附有一个关键点摘要，为广大读者提供了一个省时的内容概述。文章可能附有简单的语言摘要，以帮助患者、护理人员和其他人了解重要的医学进展。该杂志还提供了包含各种其他类型的增强功能的选项，包括幻灯片、视频和动画。所有增强功能都经过同行评审，达到与文章本身相同的高标准。同行评审是使用由国际专家数据库支持的 editorial manager® 进行的。该数据库与其他 Adis 期刊共享。

American Journal Of Cardiovascular Drugs创刊于2001年，由ADIS INT LTD出版商出版，收稿方向涵盖医学 - 心血管系统全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度>12周，或约稿，影响因子指数2.674，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。